Th17 Cells in Cancer: The Ultimate Identity Crisis

Stefanie R. Bailey(University of Virginia), Chrystal M. Paulos(Emory University)

Frontiers in Immunology

June 17, 2014

10.3389/fimmu.2014.00276

Cited by 327

Related Papers

Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells

|Cancer Immunology Research|2015|332

Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion

|JCI Insight|2017|69

Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 <sup>+</sup> T cells

|European Journal of Immunology|2020|64

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma

|Cell Reports Medicine|2021|57

Title: Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells Short Title: Constitutive CAR T-cell proliferation

|Unknown|2015|7